Skip Navigation


International Immunology Advance Access originally published online on February 27, 2008
International Immunology 2008 20(4):543-553; doi:10.1093/intimm/dxn012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/4/543    most recent
dxn012v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nagaoka, I.
Right arrow Articles by Hirata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagaoka, I.
Right arrow Articles by Hirata, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Evaluation of the effect of human β-defensins on neutrophil apoptosis

Isao Nagaoka1, François Niyonsaba2, Yuko Tsutsumi-Ishii1, Hiroshi Tamura3 and Michimasa Hirata4

1 Department of Host Defense and Biochemical Research and
2 Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo, Japan
3 Seikagaku Corporation, Tokyo, Japan
4 Insititute of Ohtaka Enzyme Co., Hokkaido, Japan

Correspondence to: I. Nagaoka; E-mail: nagaokai{at}med.juntendo.ac.jp

Peptide antibiotics possess the potent antimicrobial activities against invading microorganisms and contribute to the innate host defense. Antimicrobial human β-defensins (hBDs) not only exhibit potent bactericidal activities against Gram-negative and Gram-positive bacteria but also function as immunomodulatory molecules by inducing cytokine and chemokine production and inflammatory and immune cell activation. Neutrophil is a critical effector cell in host defense against microbial infection, and its lifespan is regulated by various pathogen- and host-derived substances. Here, to further evaluate the role of hBDs in innate immunity, we investigated the action of hBD-1 to -4 on neutrophil apoptosis. Neutrophil apoptosis was assessed using human blood neutrophils based on the morphological changes. Of note, hBD-3 most potently suppressed neutrophil apoptosis among hBD-1 to -4, accompanied with the down-regulation of truncated Bid (a pro-apoptotic protein), up-regulation of Bcl-xL (an anti-apoptotic protein) and inhibition of mitochondrial membrane potential change and caspase 3 activity. Furthermore, we revealed that neutrophils expressed CC chemokine receptor (CCR) 6, and the action of hBD-3 was completely abrogated by a neutralizing anti-CCR6 mAb. Collectively, these observations suggest that hBDs, especially hBD-3, can not only kill bacteria but also modulate (suppress) neutrophil apoptosis via the action on CCR6. Suppression of neutrophil apoptosis results in the prolongation of their lifespan and may be advantageous for the host defense against bacterial invasion.

Keywords: antimicrobial peptides, chemokine receptor, innate immunity


Transmitting editor: K. Okumura

Received 9 August 2007, accepted 23 January 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. C. Galicia, M. R. Benakanakere, P. G. Stathopoulou, and D. F. Kinane
Neutrophils rescue gingival epithelial cells from bacterial-induced apoptosis
J. Leukoc. Biol., July 1, 2009; 86(1): 181 - 186.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.